BioCentury
ARTICLE | Financial News

Maxia raises $20.5 million

June 1, 2000 7:00 AM UTC

Maxia (San Diego, Calif.), which is developing its MX6 topical small molecule inducer of apoptosis to treat high and low grade cervical intraepithelial neoplasia, raised $20.5 million in a venture rou...